Principal Financial Group’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $57.7M | Buy |
106,561
+4,869
| +5% | +$2.74M | 0.03% | 476 |
|
|
2026
Q1 | $60.3M | Buy |
101,692
+3,534
| +4% | +$1.76M | 0.03% | 429 |
|
|
2025
Q4 | $47.8M | Sell |
98,158
-7,609
| -7% | -$3.54M | 0.02% | 482 |
|
|
2025
Q3 | $44.3M | Sell |
105,767
-5,583
| -5% | -$1.88M | 0.02% | 508 |
|
|
2025
Q2 | $32M | Sell |
111,350
-511
| -0.5% | -$153K | 0.02% | 612 |
|
|
2025
Q1 | $34.5M | Buy |
111,861
+309
| +0.3% | +$106K | 0.02% | 555 |
|
|
2024
Q4 | $39.4M | Sell |
111,552
-921
| -0.8% | -$339K | 0.02% | 540 |
|
|
2024
Q3 | $40.3M | Sell |
112,473
-44,683
| -28% | -$15.1M | 0.02% | 537 |
|
|
2024
Q2 | $50.1M | Sell |
157,156
-25,835
| -14% | -$6.84M | 0.03% | 463 |
|
|
2024
Q1 | $42M | Buy |
182,991
+4,655
| +3% | +$1.05M | 0.02% | 540 |
|
|
2023
Q4 | $39.2M | Sell |
178,336
-614
| -0.3% | -$142K | 0.03% | 529 |
|
|
2023
Q3 | $40.4M | Sell |
178,950
-2,722
| -1% | -$627K | 0.03% | 481 |
|
|
2023
Q2 | $40.1M | Buy |
181,672
+1,341
| +0.7% | +$297K | 0.03% | 501 |
|
|
2023
Q1 | $40.4M | Sell |
180,331
-112,916
| -39% | -$27.8M | 0.03% | 501 |
|
|
2022
Q4 | $81.5M | Buy |
293,247
+114,114
| +64% | +$28.8M | 0.06% | 272 |
|
|
2022
Q3 | $37.5M | Sell |
179,133
-112,086
| -38% | -$25.1M | 0.03% | 470 |
|
|
2022
Q2 | $68.6M | Buy |
291,219
+138,171
| +90% | +$28.1M | 0.05% | 310 |
|
|
2022
Q1 | $27.5M | Buy |
153,048
+66
| +0% | +$12.6K | 0.02% | 715 |
|
|
2021
Q4 | $33.1M | Sell |
152,982
-2,140
| -1% | -$420K | 0.02% | 622 |
|
|
2021
Q3 | $28.6M | Sell |
155,122
-637
| -0.4% | -$125K | 0.02% | 670 |
|
|
2021
Q2 | $27.9M | Buy |
155,759
+2,685
| +2% | +$511K | 0.02% | 712 |
|
|
2021
Q1 | $25.6M | Buy |
153,074
+21,527
| +16% | +$3.59M | 0.02% | 736 |
|
|
2020
Q4 | $20M | Sell |
131,547
-464
| -0.4% | -$60.9K | 0.01% | 774 |
|
|
2020
Q3 | $13.3M | Sell |
132,011
-3,666
| -3% | -$402K | 0.01% | 897 |
|
|
2020
Q2 | $16.4M | Sell |
135,677
-31,141
| -19% | -$3.5M | 0.01% | 758 |
|
|
2020
Q1 | $15.8M | Sell |
166,818
-55,271
| -25% | -$5.25M | 0.02% | 651 |
|
|
2019
Q4 | $19.6M | Buy |
222,089
+32,242
| +17% | +$2.84M | 0.02% | 813 |
|
|
2019
Q3 | $15.1M | Sell |
189,847
-3,282
| -2% | -$264K | 0.01% | 970 |
|
|
2019
Q2 | $15.1M | Buy |
193,129
+386
| +0.2% | +$36.1K | 0.01% | 989 |
|
|
2019
Q1 | $22.6M | Buy |
192,743
+1,724
| +0.9% | +$201K | 0.02% | 680 |
|
|
2018
Q4 | $20.8M | Sell |
191,019
-2,989
| -2% | -$347K | 0.02% | 678 |
|
|
2018
Q3 | $24.8M | Buy |
194,008
+2,134
| +1% | +$264K | 0.02% | 716 |
|
|
2018
Q2 | $21.7M | Sell |
191,874
-4,359
| -2% | -$479K | 0.02% | 775 |
|
|
2018
Q1 | $22M | Buy |
196,233
+5,396
| +3% | +$685K | 0.02% | 731 |
|
|
2017
Q4 | $28.2M | Buy |
190,837
+6,096
| +3% | +$775K | 0.03% | 620 |
|
|
2017
Q3 | $21.6M | Sell |
184,741
-5,724
| -3% | -$731K | 0.02% | 725 |
|
|
2017
Q2 | $24.7M | Buy |
190,465
+7,126
| +4% | +$889K | 0.02% | 652 |
|
|
2017
Q1 | $24.8M | Buy |
183,339
+14,197
| +8% | +$2.15M | 0.03% | 595 |
|
|
2016
Q4 | $24.3M | Sell |
169,142
-1,688
| -1% | -$216K | 0.03% | 589 |
|
|
2016
Q3 | $20.2M | Buy |
170,830
+2,558
| +2% | +$307K | 0.03% | 650 |
|
|
2016
Q2 | $17.8M | Buy |
168,272
+15,907
| +10% | +$1.77M | 0.02% | 690 |
|
|
2016
Q1 | $17M | Buy |
152,365
+6,325
| +4% | +$800K | 0.02% | 670 |
|
|
2015
Q4 | $22.9M | Buy |
146,040
+4,184
| +3% | +$609K | 0.03% | 502 |
|
|
2015
Q3 | $18.6M | Sell |
141,856
-386
| -0.3% | -$61.9K | 0.03% | 576 |
|
|
2015
Q2 | $24.7M | Buy |
142,242
+4,060
| +3% | +$730K | 0.04% | 487 |
|
|
2015
Q1 | $23.8M | Buy |
138,182
+2,727
| +2% | +$416K | 0.04% | 471 |
|
|
2014
Q4 | $17.5M | Buy |
135,455
+959
| +0.7% | +$124K | 0.03% | 595 |
|
|
2014
Q3 | $17.3M | Buy |
134,496
+10,971
| +9% | +$1.13M | 0.03% | 579 |
|
|
2014
Q2 | $10.9M | Sell |
123,525
-4,215
| -3% | -$405K | 0.02% | 873 |
|
|
2014
Q1 | $12M | Sell |
127,740
-225,076
| -64% | -$23M | 0.02% | 788 |
|
|
2013
Q4 | $39.9M | Buy |
352,816
+232,323
| +193% | +$20.9M | 0.07% | 309 |
|
|
2013
Q3 | $9.5M | Sell |
120,493
-5
| -0% | -$365 | 0.02% | 838 |
|
|
2013
Q2 | $7.93M | Buy |
+120,498
| New | +$7.76M | 0.02% | 899 |
|
Other funds holding UTHR
ACA
JT
Principal Financial Group's UTHR Position: Q2 2026 in Review
Principal Financial Group increased its United Therapeutics (UTHR) stake by 4.8% in Q2 2026, buying an estimated $2.74M and bringing the position to 106,561 shares worth $57.7M. The position accounts for 0.03% of the portfolio, ranked #476.
Principal Financial Group first reported a position in UTHR in Q2 2013 and has held it in 53 quarters since. The position peaked at $81.5M in Q4 2022. 878 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.
- Principal Financial Group held 106,561 shares of United Therapeutics worth $57.7M as of Q2 2026.
- Principal Financial Group bought 4,869 United Therapeutics shares in Q2 2026, an estimated $2.74M.
- United Therapeutics made up 0.03% of Principal Financial Group's portfolio in Q2 2026, its #476 holding.
- Principal Financial Group first reported a position in United Therapeutics in Q2 2013 and has held it in 53 quarters since.
- Principal Financial Group's United Therapeutics position peaked at $81.5M in Q4 2022.
- 878 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.
Based on Principal Financial Group's 13F filing for Q2 2026, filed 4 Aug 2026.